Mice were purchased from the Jackson Laboratory (GSK-3βFL, Stock No 029592; NPHS-Cre, Stock No 008205), and the podocyte-specific GSK-3β-KO mice were generated as described previously [35 (link)]. The grouping and treatment protocols used in the aforementioned lncRNA Dlx6-os1 overexpression study with the db/m mice were adapted for this experiment.
Free full text: Click here